Mirum Pharmaceuticals Inc (NAS:MIRM)
$ 41.56 -0.47 (-1.12%) Market Cap: 2.02 Bil Enterprise Value: 2.06 Bil PE Ratio: 0 PB Ratio: 8.69 GF Score: 51/100

Mirum Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 08:15PM GMT
Release Date Price: $29.96 (-3.54%)
Unidentified Analyst

Great. Thank you, everyone, for coming, and we certainly did save the best company for last. We have the pleasure of having Chris Peetz from Mirum Pharmaceuticals today. My name is (inaudible). I'm an Executive Director at Morgan Stanley Investment Banking division.

I have a brief disclosure that I need to read before we get started. Research disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

So with that, Chris, thank you very much for making the trek out here. We really appreciate you making the time. Really excited to have you here today.

Questions & Answers

Unidentified Analyst

Maybe before we jump in, can you tell us about Mirum story and how you first got involved and how you got to where you are today before we dive into some of your most recent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot